$MAZE news
The latest MAZE stock news: headlines, filings, AI summaries and sentiment for $MAZE, updated around the clock.
- Maze Therapeutics Reports Q3 2026 GAAP EPS of -$0.79 and Increased Net Loss
- Maze Therapeutics, Inc. - 10-Q Filing
- Maze Therapeutics, Inc. - 8-K Filing
- Maze Therapeutics' CMO Sells Entire Direct Stock Stake for $255K
- Maze Therapeutics' CMO Sells Entire Direct Stake for $255K
- Maze Therapeutics CEO Sells Nearly 28K Shares Indirectly
- Maze Therapeutics, Inc. - 8-K Filing
- Maze Therapeutics, Inc. - 10-Q Filing
- Maze Therapeutics, Inc. - 8-K Filing
- Maze Therapeutics CSBO Sells 7,500 Shares Following Strong Trial Results and Q4 Financials